Grant and Funding Programs Offered by Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)

Role of Innovative Medicines Canada in the funding ecosystem

Innovative Medicines Canada is the national association for Canada’s innovative pharmaceutical industry. The organization’s main role is advocacy and policy leadership, but its website also documents funding activity through its affiliated Health Research Foundation and scholarship partnerships.

Funding and support activities evidenced on the site

• The Health Research Foundation of Innovative Medicines Canada states that it funds applied research and recognizes research excellence.
• Site news includes award nominations such as the Diversity and Equity in Research Award, showing support for Canadian researchers.
• A joint announcement with Roche Canada created the Brigitte Nolet Scholarship for Indigenous pathways into life sciences at York University, including a $50,000 gift.

Organization profile and scope

The association represents member companies across Canada’s innovative medicines sector and works on access to medicines, pharmacare, rare disease policy, private drug coverage, and related health-system topics. It was founded in 1914 and adopted the name Innovative Medicines Canada in 2016.

Publics supported and overall impact

Through the Health Research Foundation, awards, and scholarship initiatives, the organization supports researchers, students, and academic health research while also advancing industry-wide health policy goals in Canada.